OTCMKTS:CSLLY CSL (CSLLY) Stock Price, News & Analysis $101.92 +1.06 (+1.05%) (As of 09/12/2024 ET) Add Compare Share Share Today's Range$99.50▼$105.6650-Day Range$96.69▼$105.6352-Week Range$71.51▼$109.00Volume35,541 shsAverage Volume19,223 shsMarket Capitalization$98.51 billionP/E RatioN/ADividend Yield1.32%Price TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisAnalyst ForecastsChartFinancialsHeadlinesSEC FilingsShort Interest Get CSL alerts: Email Address CSL MarketRank™ Stock AnalysisAnalyst RatingN/AUpside/DownsideN/AShort InterestHealthy0.00% of Shares Sold ShortDividend StrengthWeakBased on Four FactorsSustainabilityN/ANews Sentiment0.07Based on 2 Articles This WeekInsider TradingN/AProj. Earnings Growth17.84%From $3.42 to $4.03 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.04 out of 5 stars N/A Analyst's Opinion Consensus RatingThere is not enough analysis data for CSL.Read more about CSL's stock forecast and price target. Previous Next 5.0 Short Interest Percentage of Shares Shorted0.00% of the outstanding shares of CSL have been sold short.Short Interest Ratio / Days to CoverCSL has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in CSL has recently decreased by 33.33%, indicating that investor sentiment is improving significantly. Previous Next 1.7 Dividend Strength Dividend YieldCSL pays a meaningful dividend of 1.34%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthCSL does not have a long track record of dividend growth.Dividend SustainabilityBased on earnings estimates, CSL will have a dividend payout ratio of 33.50% next year. This indicates that CSL will be able to sustain or increase its dividend.Read more about CSL's dividend. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for CSLLY. Previous Next 2.3 News and Social Media Coverage News SentimentCSL has a news sentiment score of 0.07. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.71 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for CSL this week, compared to 1 article on an average week.Search Interest1 people have searched for CSLLY on MarketBeat in the last 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, CSL insiders have not sold or bought any company stock.Percentage Held by InstitutionsOnly 0.03% of the stock of CSL is held by institutions.Read more about CSL's insider trading history. Previous Next 1.9 Earnings and Valuation Earnings GrowthEarnings for CSL are expected to grow by 17.84% in the coming year, from $3.42 to $4.03 per share.Price to Earnings Growth RatioCSL has a PEG Ratio of 2.01. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioCSL has a P/B Ratio of 5.52. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Banyan Hill PublishingYou won’t believe what this ex-Wall Street insider discovered about the electionOne ex-Wall Street insider recently combed through 64 years of election data… And he just uncovered something surprising about the presidential elections… It turns out that for the past 64 years, the stock market has soared during election seasons - regardless of whether a Democrat or Republican is elected. In other words, if you're sitting on the sidelines because you're worried about how the market will react to a Trump or Kamala win, you could be missing out on some serious profits.Learn all about it here. About CSL Stock (OTCMKTS:CSLLY)CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants. The CSL Seqirus segment provides influenza related products and pandemic services to governments. The CSL Vifor segment offers products in the therapeutic areas of iron deficiency and nephrology. The company also licenses CSL intellectual property. CSL Limited was founded in 1916 and is headquartered in Melbourne, Australia.Read More CSLLY Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CSLLY Stock News HeadlinesSeptember 13 at 8:15 AM | prnewswire.comJapan's Ministry of Health, Labor and Welfare Approves CSL and Arcturus Therapeutics' Updated Self-amplifying mRNA COVID-19 Vaccine for Protection against JN.1 Strain, to be Distributed in Japan by Meiji Seika PharmaAugust 19, 2024 | seekingalpha.comCSL Limited: Good Results Overshadowed By Below-Expectations GuidanceSeptember 13, 2024 | Behind the Markets (Ad)The $15 Stock Powering NVIDIA, TESLA and MicrosoftThe Biggest AI firms in the world...Tesla... Microsoft... NVIDIA... Are all relying on a little-known supplier, which provides a crucial building block for AI.August 18, 2024 | markets.businessinsider.comAnalysts Conflicted on These Healthcare Names: CSL (OtherCMXHF), Pro Medicus Limited (OtherPMCUF) and Takeda Pharmaceutical Co (OtherTKPHF)August 15, 2024 | finance.yahoo.comCSL Full Year 2024 Earnings: EPS Misses ExpectationsAugust 15, 2024 | markets.businessinsider.comMorgans Sticks to Their Buy Rating for CSL (CMXHF)August 15, 2024 | morningstar.com.auCSL results: ASX 200 giant announces solid earnings but shares fallAugust 15, 2024 | markets.businessinsider.comCSL (CMXHF) Receives a Buy from UBSSeptember 13, 2024 | Behind the Markets (Ad)The $15 Stock Powering NVIDIA, TESLA and MicrosoftThe Biggest AI firms in the world...Tesla... Microsoft... NVIDIA... Are all relying on a little-known supplier, which provides a crucial building block for AI.August 14, 2024 | msn.comCSL shares on watch amid US$3b FY 2024 profitAugust 14, 2024 | seekingalpha.comCSL Limited (CSLLY) Q4 2024 Earnings Call TranscriptAugust 13, 2024 | afr.com‘I want to win every time’: The Olympic-style goal driving CSL’s bossAugust 12, 2024 | msn.comRobust demand for blood products drives CSL's growthAugust 12, 2024 | marketwatch.comCSL Annual Profit Rises by 20% on Immunoglobulins Growth -- UpdateAugust 12, 2024 | msn.comCSL share price tumbles after FY25 guidance disappointsAugust 8, 2024 | au.investing.comCSL Ltd (ASX: CSL) Set to Reveal Earnings and Dividend DetailsAugust 8, 2024 | morningstar.com.auCSL earnings preview: What to look for in ASX200 heavyweight's resultsAugust 2, 2024 | fxstreet.comCSL Limited Elliott Wave technical forecast [Video]See More Headlines Receive CSLLY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for CSL and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today9/13/2024Fiscal Year End6/30/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolOTCMKTS:CSLLY CUSIPN/A CIK1274152 Webwww.csl.com.au Phone(139) 389-1911Fax61-3-9389-1434Employees32,000Year Founded1904Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E Ratio29.80 P/E Growth2.01Net IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio0.58 Current Ratio2.18 Quick RatioN/A Sales & Book Value Annual Sales$14.80 billion Price / Sales6.66 Cash Flow$4.02 per share Price / Cash Flow25.35 Book Value$18.48 per share Price / Book5.52Miscellaneous Outstanding Shares966,510,000Free FloatN/AMarket Cap$98.51 billion OptionableNot Optionable Beta0.77 The Best High-Yield Dividend Stocks for 2024Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report Key ExecutivesDr. Paul F. McKenzie Ph.D. (Age 58)MD, CEO & Executive Director Comp: $2.75MMs. Joy Carolyn Linton B.Com. (Age 59)BComm, GAICD, Grad Dip AFI, Chief Financial Officer Comp: $2.05MMr. Mark DehringHead of Investor RelationsMr. Gregory Boss B.S. (Age 63)BS(Hons), J.D., Executive VP of Legal & General Counsel Comp: $1.1MChristina HickieSenior Manager of CommunicationsMs. Roanne ParryChief Human Resources OfficerDr. Karen Etchberger (Age 66)Executive Vice President of Quality & Business Services Comp: $1.03MMs. Jemimah BrennanHead of Communications - Asia PacificDr. Andrew D. Nash BSc (Hons) (Age 62)GAICD, Ph.D., Senior Vice President of Research Dr. William Mezzanotte M.D. (Age 65)M.P.H., Executive VP & Head of Research and Development Comp: $1.46MMore ExecutivesKey CompetitorsAbbVieNYSE:ABBVMerck & Co., Inc.NYSE:MRKRocheOTCMKTS:RHHBYAstraZenecaNASDAQ:AZNNovartisNYSE:NVSView All Competitors Should I Buy CSL Stock? CSLLY Pros and Cons Explained Pros Here are some ways that investors could benefit from investing in CSL Limited: CSL Limited has a strong track record of researching, developing, and distributing biopharmaceuticals and vaccines globally, showcasing expertise in the pharmaceutical preparations industry. The company operates through different segments, including CSL Behring, CSL Seqirus, and CSL Vifor, diversifying its product offerings and revenue streams. Recent developments in gene therapies and recombinants by CSL Behring have shown promising results, indicating potential for future growth and innovation. CSL Seqirus provides influenza-related products and pandemic services, which could see increased demand during health crises, contributing to revenue stability. Considering the current stock price of CSL Limited, which is $104.43 as of the record date, there may be an opportunity for investors to enter at a favorable valuation. Cons Investors should be bearish about investing in CSL Limited for these reasons: CSL Limited's institutional ownership percentage is currently at 0, indicating lower confidence from larger investors, which could impact stock performance. The company's outstanding shares information is not available, making it challenging for investors to assess the full extent of CSL Limited's market capitalization. With a month-to-month change percentage of -0.9464 in shares shorted, there might be bearish sentiment in the market regarding CSL Limited's future prospects. CSL Limited's float size is reported as 0, which could potentially lead to higher volatility in the stock price due to limited available shares for trading. The company's fifty-two-week performance shows a minimal increase of 0.0025, suggesting relatively stable but possibly slow growth compared to other investments. These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Wednesday, September 4, 2024. Please send any questions or comments about these CSL pros and cons to contact@marketbeat.com. CSLLY Stock Analysis - Frequently Asked Questions How have CSLLY shares performed this year? CSL's stock was trading at $97.17 at the start of the year. Since then, CSLLY stock has increased by 4.9% and is now trading at $101.92. View the best growth stocks for 2024 here. How do I buy shares of CSL? Shares of CSLLY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:CSLLY) was last updated on 9/13/2024 by MarketBeat.com Staff From Our PartnersInvest before this deal closes on 9/18This company can create aviation fuels from waste, they qualify to help airlines meet net-zero carbon pledges ...Deal Maker | SponsoredYou won’t believe what this ex-Wall Street insider discovered about the electionOne ex-Wall Street insider recently combed through 64 years of election data… And he just uncovered somethi...Banyan Hill Publishing | SponsoredBiden's Executive Order, Dems Digital Money Legislation, First Step ToDonald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans...Monetary Gold | SponsoredAmerica dodged a crisis — next time it could be much worseLegendary financial forecaster, Dr. Martin Weiss, has been warning us about it for months … He believes the...Weiss Ratings | SponsoredThe $15 "Insider Secret" That Could Save Your RetirementWhat if I told you there's a $15 stock that a billionaire insider just poured $47 MILLION into? That's righ...Behind the Markets | SponsoredTrump’s weapon lurks in abandoned AmericaUnemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. ...Porter & Company | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CSL Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share CSL With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CSLLY Stock Alerts